Nijmegen (the Netherlands) and Bresso (Italy)- 9th December 2020
Symeres and Axxam have further consolidated their strategic relationship, providing integrated drug discovery and development services to clients around the world, by announcing the transfer of a library of approx. 80,000 lead-like compounds, Symegold, to Axxam for use in high-throughput screens.
